Novartis Agrees to $6.8 Billion Medicines Co. Deal

The video discusses Novartis' strategic expansion through acquiring a company, offering a 45% premium to shareholders. The acquisition is driven by a promising cholesterol drug expected to generate significant sales by 2024. The drug has already tripled the company's shares in anticipation of its success.

What was the market reaction to the anticipation of the new cholesterol drug?

How much revenue is the new drug expected to generate by 2024?